Skip to main content

Advertisement

Log in

The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Fluorophotometry and pneumotonography were performed to investigate the effect of Latanoprost 0.005% and Placebo on aqueous humor flow and total outflow facility in human glaucomatous eyes.

Methods

In a randomised double-blind clinical study patients with POAG and OHT received either latanoprost 0.005% or placebo once in the evening. Fluorophotometry (Fluorotron Master II, Ocumetrics) and Pneumatonography (Model 30 Classic Pneumatonometer, Mentor) was performed in 20 eyes of 10 patients (verum) and 22 eyes of 11 patients (placebo). During a 2 week wash-out period all patients received a systemic antiglaucomatous therapy (Acetazolamide) up to 3 days before baseline measurement. Patients with an IOP higher than 28 mmHg at baseline were excluded. Fluorophotometry, tonography and IOP were measured at baseline after 1 and 2 weeks of treatment. Data was analysed by the Student’s paired t test.

Results

All patients completed the protocol. The IOP significantly decreased (25%) after 1 and 2 weeks of treatment with Latanoprost (p<0.01). Fluorophotometry measurements showed no difference in flow over time in both groups. Although tonographic mean C values in both groups did not show any difference over time, the estimated total outflow facility C (Goldmann) increased significantly (p<0.05) in the verum-treated eyes after 2 weeks. A significant difference of outflow coefficient correlated to normal pressure (P0/C) was found after 2 weeks of treatment with Latanoprost (p<0.05).

Conclusions

In accordance with the literature we found a mean 25% decrease in IOP after 2 weeks of treatment with Latanoprost 0.005%. The analysis of flow values in both groups showed no increase or decrease in aqueous humor dynamics as proved in many previous studies. The known effect of Latanoprost to increase uveoscleral outflow by remodeling extracellular matrix and widening intermuscular spaces in the ciliary body may not be detected by pneumatonography after 2 weeks of treatment. The significant increase in estimated total outflow facility (Goldmann formula) in latanoprost-treated eyes and the decrease of IOP took place at constant flow rates. The increase in conventional outflow facility may indicate trabecular meshwork changes, but it cannot explain the significant decrease in IOP. Furthermore, an additional effect, e.g. uveoscleral outflow, may play the major role as considered in many previous studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anthony TL, Pierce KL, Stamer WD, Regan JW (1998) Prostaglandin F2α receptors in the human trabecular meshwork. Invest Ophthalmol Vis Sci 39:315–321

    CAS  PubMed  Google Scholar 

  2. Ayvazian JH, Ayvazian LF (1961) A study of the hyperuricemia induced by hydrochlorothiazide and acetazolamide. J Clin Invest 40:196

    PubMed  Google Scholar 

  3. Brubaker RF (1991) Flow of aqueous humor in humans. Invest Ophthalmol Vis Sci 32:3145

    CAS  PubMed  Google Scholar 

  4. Camras CB, Siebold EC, Lustgarten JS et al. (1989) Maintained reduction of intraocular pressure by prostaglandin F -1-iospropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology 96:1329–1337

    CAS  PubMed  Google Scholar 

  5. Camras CB et al. (1987) Multiple dosing of prostaglandin F2a or epinephrine on cynomolgus monkey eyes: I. Aqueous humor dynamics. Invest Ophthalmol Vis Sci 28:463

    CAS  PubMed  Google Scholar 

  6. Camras CB et al. (1988) Multiple dosing of prostaglandin F2a or epinephrine on cynomolgus monkey eyes. III. Histopathology. Invest Ophthalmol Vis Sci 29:1428

    CAS  PubMed  Google Scholar 

  7. Crawford K, Kaufman PL, Gabelt BT (1987) Effects of topical PGF2a on aqueous humor dynamics in cynomolgus monkeys. Curr Eye Res 6:1035

    CAS  PubMed  Google Scholar 

  8. Fristrom B, Nilsson SE (1993) Interaction of PHXA41, a new prostaglandin analogue, with pilocarpine: a study on patients with elevated intraocular pressure. Arch Ophthalmol 111:662–665

    CAS  PubMed  Google Scholar 

  9. Gabelt B, Kaufman P (1998) Normal physiology. In: Alm A, Weinreb R (eds) Uveoscleral outflow. Mosby-Wolfe, London, pp 25–40

  10. Gabelt B, Kaufman P (2000) Uveoscleral outflow decreased in old rhesus monkeys. Invest Ophthalmol Vis Sci 41:253

    Google Scholar 

  11. Gabelt BT, Kaufman PL (1989) Prostaglandin F increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res 49:389–402

    Article  CAS  PubMed  Google Scholar 

  12. Gabelt BT, Kaufman PL (1990) The effect of prostaglandin F on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res 51:87–91

    Article  CAS  PubMed  Google Scholar 

  13. Goodfield M, Davis J, Jeffcoate W (1982) Acetazolamide and symptomatic metabolic acidosis in mild renal failure. Br Med J 284:422

    CAS  Google Scholar 

  14. Grant WM (1950) Tonographic method for measuring the facility and rate of aqueous flow in human eyes. Arch Ophthalmol 44:204

    Google Scholar 

  15. Grant WM (1951) Clinical measurements of aqueous outflow. Arch Ophthalmol 46:113

    CAS  Google Scholar 

  16. Hoskins D, Kass MA (1989) Tables for tonometry and tonography. In: Hoskins D, Kass MA (eds) Becker-Shaffer’s diagnosis and therapy of the glaucomas, 6th edn. Mosby, St. Louis

  17. Kaufman PL (1986) Effects of intracamerally infused prostaglandins on outflow facility in cynomolgus monkey eyes with intact or retrodisplaced ciliary muscle. Exp Eye Res 43:819

    CAS  PubMed  Google Scholar 

  18. Lee PY, Podos SM, Severin C (1984) Effect of prostaglandin F2a on aqueous humor dynamics of rabbit, cat, and monkey. Invest Ophthalmol Vis Sci 25:1087

    CAS  PubMed  Google Scholar 

  19. Linner E (1955) Episcleral venous pressure during tonography. Acta XVII Congr Ophthalmol 3:1532

    Google Scholar 

  20. Lutjen-Drecoll E, Tamm E (1988) Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2a. Exp Eye Res 47:761

    Article  CAS  PubMed  Google Scholar 

  21. Nilsson SF et al. (1989) Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2a-1-isopropylester in the cynomolgus monkey. Exp Eye Res 48:707

    Article  CAS  PubMed  Google Scholar 

  22. Pederson JE, Gaasterland DE, MacLellan HM (1977) Uveoscleral aqueous outflow in the rhesus monkey: importance of uveal reabsorption. Invest Ophthalmol Vis Sci 16:1008

    CAS  PubMed  Google Scholar 

  23. Selen G et al. (1991) Effects of PhXA34 and PhDA100A, two phenyl substituted prostaglandin esters, on aqueous humor dynamics and microcirculation in the monkey eye. Invest Ophthalmol Vis Sci 32 (Suppl):869

    Google Scholar 

  24. Svedbergh B, Forsberg I (1993) A morphological study on the effects of chronic administration of latanoprost (LP) on the ciliary muscle and trabecular meshwork in monkeys. Invest Ophthalmol Vis Sci 34 (Suppl):932

    Google Scholar 

  25. Tamm E, Rittig M, Lutjen-Drecoll E (1990) Electromikroskopische and immunohistochemische Untersuchungen zur augendrucksenkender Wirkung von Prostaglandin F2a. Fortschr Ophthalmol 87:623

    CAS  PubMed  Google Scholar 

  26. Toris C, Yablonski M, Wang Y, Camras C (1999) Aqueous humor dynamics in the aging human eye. Am J Ophthalmol 127:407–412

    Article  CAS  PubMed  Google Scholar 

  27. Toris CB, Camras CB, Yablonski ME (1993) Effects of PhXA41, a new prostaglandin F2a analog, on aqueous humor dynamics in human eyes. Ophthalmology 100:1297

    CAS  PubMed  Google Scholar 

  28. Tripathi RC (1977) Uveoscleral drainage of aqueous humour. Exp Eye Res 25 (Suppl):305

    Article  PubMed  Google Scholar 

  29. Tripathi RC, Tripathi BJ (1982) Functional anatomy of the anterior chamber angle. In: Jacobiec FA (ed) Ocular anatomy, embryology, and teratology. Harber and Row, Philadelphia, p 276

  30. Tripathi RC (1972) Aqueous outflow pathway in normal and glaucomatous eye. Br J Ophthalmol 56:157–174

    CAS  PubMed  Google Scholar 

  31. Tripathi RC, Yang C, Tripathi BJ, Borisuth NS (1992) Role of receptors in the trabecular meshwork of the eye as targeted to the development of antiglaucoma therapy. Drug Development Res 27:191–228

    CAS  Google Scholar 

  32. Villumsen J, Alm A (1989) Prostaglandin F -isopropylester eye drops: effects in normal human eyes. Br J Ophthalmol 73:419–426

    CAS  PubMed  Google Scholar 

  33. Villumsen J (1992) Effects in human eyes of topical prostaglandin F - isopropylester and 17-phenyl substituted analogues of prostaglandin F - isopropylester. Umea University Medical Dissertations. ISSN 0346–6612

  34. Wiederholt M, Thieme H, Stumpff F (2000) The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retinal Eye Res 19:271–295

    Article  CAS  Google Scholar 

  35. Ziai N, Dolan JW, Kacere RD, Brubaker RF (1993) The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 111:1351–1358

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

The study was supported by a grant from Pharmacia GmbH, Erlangen, Germany

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sven Dinslage.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dinslage, S., Hueber, A., Diestelhorst, M. et al. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study. Graefe's Arch Clin Exp Ophthalmol 242, 654–660 (2004). https://doi.org/10.1007/s00417-003-0835-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-003-0835-1

Keywords

Navigation